
Sign up to save your podcasts
Or


Gilead’s experimental Covid-19 treatment caught the markets’ attention after STAT News reported encouraging early results in its phase 3 trial. Former FDA Commissioner Dr. Scott Gottlieb explains the antiviral Remdesivir and explains its potential role in flattening the pandemic’s curve. French pharmaceutical company Sanofi has partnered with peer GlaxoSmithKline to develop a Covid-19 vaccine in the next 18 months. Sanofi has also partnered with a startup to create a coronavirus test using a smartphone. CEO Paul Hudson explains the news, the technology, and the path ahead for a healthier planet.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.2
526526 ratings
Gilead’s experimental Covid-19 treatment caught the markets’ attention after STAT News reported encouraging early results in its phase 3 trial. Former FDA Commissioner Dr. Scott Gottlieb explains the antiviral Remdesivir and explains its potential role in flattening the pandemic’s curve. French pharmaceutical company Sanofi has partnered with peer GlaxoSmithKline to develop a Covid-19 vaccine in the next 18 months. Sanofi has also partnered with a startup to create a coronavirus test using a smartphone. CEO Paul Hudson explains the news, the technology, and the path ahead for a healthier planet.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,100 Listeners

1,366 Listeners

239 Listeners

151 Listeners

518 Listeners

1,173 Listeners

2,175 Listeners

325 Listeners

67 Listeners

153 Listeners

289 Listeners

34 Listeners

45 Listeners

2,145 Listeners

1,320 Listeners

591 Listeners

5 Listeners

21 Listeners

1,573 Listeners

212 Listeners

409 Listeners

300 Listeners

122 Listeners

830 Listeners

175 Listeners

37 Listeners

15 Listeners

33 Listeners

11 Listeners

16 Listeners

0 Listeners